The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Osteoblasts play key roles in the mechanisms of action of strontium ranelate
Open accessAbstract
Background and purpose: Strontium ranelate reduces fracture risk in postmenopausal women with osteoporosis. Evidence from non‐clinical studies and analyses of bone markers in phase III trials indicate that this is due to an increase in osteoblast formation and a decrease of osteoclastic resorption. The aim of this work was to investigate, in human cells, the mechanisms by which strontium ranelate is able to influence the activities of osteoblasts and osteoclasts. Experimental approach: Human primary osteoblasts were used to examine effects of strontium ranelate on replication (thymidine incorporation), differentiation (Runx2 and alkaline phosphatase) and cell survival (cell counts and caspase activity). Osteoprotegerin (OPG) was measured by quantitative reverse transcription PCR (qRT‐PCR) and elisa and receptor activator of NFκB ligand (RANKL) by qRT‐PCR and Western blot. As strontium ranelate has been proposed as an agonist of the calcium‐sensing receptor (CaSR), the involvement of CaSR in the effects of strontium ranelate on OPG and RANKL expression, and cell replication was examined using siRNA. Key results: Strontium ranelate increased mRNA and protein levels of OPG and suppressed those of RANKL. Strontium ranelate also stimulated osteoblast replication and differentiation and increased cell survival under stress. Knocking down CaSR suppressed strontium ranelate‐induced stimulation of OPG mRNA, reduction of RANKL mRNA, and increase in replication, indicating the involvement of CaSR in these responses. Conclusions and implications: Our results demonstrate that osteoblasts play a key role in the mechanism of action of the anti‐fracture agent, strontium ranelate by mediating both its anabolic and anti‐resorptive actions, at least in part, via activation of CaSR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Weinstein, R. S., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2799 · Cited by 1,753 · cited 2×
“…fracture risk (Bonewald, 2004; Almeida et al., 2007), and it is well established that the protective mechanism of oestrogen to reduce fracture risk in patients with glucocorticoid-induced osteoporosis includes an increased osteoblast and osteocyte lifespan (Weinstein et al., 1998; Dennison, 1999).”
BackgroundMinireview: The OPG/RANKL/RANK System
Khosla, S. (2001) · Endocrinology · doi:10.1210/endo.142.12.8536 · Cited by 1,515
Cited by
Alloying design of biodegradable zinc as promising bone implants for load-bearing applications
Yang, H., Jia, B., Zhang, Z., Qu, X., Li, G., Lin, W., Zhu, D., Dai, K., & Zheng, Y. (2020) · Nature Communications · doi:10.1038/s41467-019-14153-7 · Cited by 756
The effects of strontium-substituted bioactive glasses on osteoblasts and osteoclasts in vitro
Gentleman, E., Fredholm, Y. C., Jell, G., Lotfibakhshaiesh, N., O'Donnell, M. D., Hill, R. G., & Stevens, M. M. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.121 · Cited by 635
Aging and bone loss: new insights for the clinician
Demontiero, O., Vidal, C., & Duque, G. (2012) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x11430858 · Cited by 559
The calcium-sensing receptor in bone cells: A potential therapeutic target in osteoporosis
Marie, P. J. (2010) · Bone · doi:10.1016/j.bone.2009.07.082 · Cited by 281
Osteoblasts in osteoporosis: Past, emerging, and future anabolic targets
Marie, P. J., & Kassem, M. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0132 · Cited by 234
Metadata
- Authors
- Brennan, T., Rybchyn, M., Green, W., Atwa, S., Conigrave, A., & Mason, R.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2009-07-23
- Volume
- 157
- Issue
- 7
- Pages
- 1291-1300
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2009756491
- Cited by
- 248
- References
- 2
- FWCI
- 7.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Osteoblasts play key roles in the mechanisms of action of strontium ranelate. https://app.cochat.ai/papers/10.1111/j.1476-5381.2009.00305.x
- The paper
- Brennan, T., Rybchyn, M., Green, W., Atwa, S., Conigrave, A., & Mason, R. (2009). Osteoblasts play key roles in the mechanisms of action of strontium ranelate. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2009.00305.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.